In House vs Accredited Testing for Medical Devices

A failed dielectric strength test, an unexpected acoustic output result, or incomplete traceability can change a verification schedule quickly. The decision between in house vs accredited testing affects more than cost and turnaround time. It determines how readily test data can support design decisions, risk management, supplier controls, and regulatory submissions.

For medical device manufacturers, the appropriate model depends on the product, the applicable standard, the intended use of the data, and the consequences of an inconclusive or challenged result. Internal capability can accelerate development. Accredited laboratory testing can provide documented confidence when data will carry regulatory or market-access significance.

The central distinction is not simply whether testing occurs at a company facility or an external laboratory. It is whether the work is performed under a quality system that has been independently assessed for technical competence within a defined scope.

An internal engineering lab may have highly capable personnel, well-maintained instruments, and effective procedures. Its testing can be valuable for feasibility studies, iterative design work, troubleshooting, and pre-compliance screening. However, the manufacturer is responsible for demonstrating that methods, equipment, personnel competency, environmental controls, calibration, and records are adequate for the intended use of the results.

An ISO/IEC 17025-accredited laboratory operates within a system assessed by an accreditation body. Accreditation applies to specified test methods, standards, or measurement capabilities, not to every activity a laboratory performs. Within its scope, the lab must demonstrate technical competency, traceability of measurements, controlled methods, suitable equipment, qualified personnel, and documented quality processes.

That distinction matters when a reviewer, notified body, customer, or internal quality organization asks a practical question: Can the reported result be defended, reproduced, and traced to a controlled test process?

Accreditation Is Scope-Specific

A laboratory’s accreditation status should not be treated as a blanket qualification. A lab may be accredited for particular electrical safety evaluations, acoustic measurements, or ultrasound performance tests while other services fall outside its accredited scope.

Before assigning work, manufacturers should confirm that the relevant standard, test method, and product category are covered. This is particularly important for specialized medical device testing, where a general capability statement may not establish competency for a device-specific configuration or measurement requirement.

Where Internal Testing Delivers Value

Internal testing is often the fastest way to support engineering decisions. Development teams can test prototypes immediately, investigate design changes without formal sample intake, and repeat measurements as hardware or software evolves. This feedback loop is especially useful before design freeze, when the purpose is to identify failure modes rather than generate final evidence.

For example, an ultrasound manufacturer may use internal tools to monitor output trends across transducer revisions. An ECG device team may conduct repeated checks of basic electrical performance as firmware changes. An endoscope developer may use internal fixtures to assess durability or functional behavior during iterative design.

These activities can reduce the number of costly surprises that reach formal verification. They also help teams arrive at an accredited laboratory with stable samples, a defined configuration, and a clearer understanding of likely risks.

Internal testing is most effective when it is intentionally governed. Even where results are not intended for external submission, teams benefit from controlled procedures, current calibrations, documented acceptance criteria, representative test articles, and retained raw data. Informal bench testing has a place, but it should not be confused with verification evidence.

Where Accredited Testing Carries More Weight

Accredited testing is generally appropriate when the data will support a regulatory submission, a formal declaration of conformity, an independent verification claim, or a high-risk design decision. It is also valuable when a manufacturer needs testing against a recognized IEC or ISO standard and requires records that demonstrate an established technical and quality framework.

The benefit is not merely the final report. It is the controlled chain behind the report: confirmed sample identification, defined test conditions, calibrated measurement systems, documented deviations, review of technical records, and a clear statement of results against the applicable criteria.

For US market submissions, FDA ASCA recognition may add further relevance when a test laboratory and applicable consensus standard are within the program’s scope. Manufacturers should evaluate the specific submission strategy and standard requirements rather than assume that any external report provides the same regulatory value.

Accredited third-party work can also help separate development ownership from verification execution. That independence is useful when internal teams have invested heavily in a design and need objective evidence that performance or safety requirements have been met.

Choose Based on the Risk of the Decision

The right question is not, “Is internal testing cheaper?” It is, “What is the cost if this result is later insufficient?” A missed requirement near submission, a questionable measurement during an audit, or a retest caused by poor documentation can consume far more time than an early, properly scoped external evaluation.

Several factors should guide the decision:

• Regulatory reliance: Data intended for a 510(k), other regulatory filing, or formal compliance package usually warrants accredited testing aligned to the applicable standard.
• Measurement complexity: Tests involving acoustic power, ultrasound image quality, leakage current, dielectric strength, electromagnetic performance, or specialized materials analysis often require equipment and expertise that are difficult to maintain internally.
• Design maturity: Early prototypes benefit from internal screening. Stable, production-representative units are better candidates for formal external testing.
• Risk profile: The greater the potential impact on patient safety, essential performance, or market access, the stronger the case for independent, controlled evidence.

The answer may vary within one verification plan. A manufacturer can reasonably conduct hundreds of internal development checks while outsourcing a defined set of standards-based tests that require accredited capability.

Consider the Total Schedule, Not the Test Date

Internal testing can appear faster because no samples need to be shipped and no formal quotation or scheduling process is required. That advantage is real for quick iterations. But the total schedule changes if the internal result cannot be used for the final purpose and the product must later be retested externally.

External testing also requires planning. The laboratory needs the correct device configuration, accessories, software version, instructions for use, test fixtures, and applicable standards. A clear test plan before sample shipment reduces avoidable questions and protects the laboratory schedule.

Manufacturers should identify the compliance-critical tests early, even if formal testing will occur later. Early discussion of standards, sample quantities, worst-case configurations, and acceptance criteria helps prevent a late-stage discovery that the available prototype is not representative or that a necessary accessory was omitted.

A Practical Hybrid Model

For many medical device programs, the most effective approach is not choosing one model exclusively. It is assigning each activity to the environment best suited to its purpose.

Use internal resources for exploratory work, design optimization, engineering characterization, and screening against expected failure modes. Use an accredited laboratory for formal verification, specialized measurements, and evidence intended to withstand regulatory review or customer scrutiny.

The transition should be deliberate. Before external testing begins, freeze the relevant design configuration, document the device under test, confirm software and accessory versions, and review prior internal results for trends that may affect formal performance. If the test article differs from the eventual production configuration, document the rationale and assess the impact through the design control process.

This model avoids treating the external laboratory as a last-minute rescue step. It also avoids burdening internal teams with maintaining every specialized test capability required across a product portfolio.

Selecting an Accredited Testing Partner

A suitable laboratory should be evaluated on more than its accreditation certificate. Confirm its scope, experience with the device technology, familiarity with the applicable standards, equipment capacity, reporting practices, and ability to clarify test assumptions before work begins.

For specialized devices, technical fit is decisive. A laboratory that understands ultrasound output measurement, endoscope evaluation, physiotherapy system performance, or electrical safety requirements can identify configuration issues that might otherwise surface after testing starts. Sigma Scientific Services, for example, supports medical device manufacturers with ISO/IEC 17025-accredited and FDA ASCA-recognized testing capabilities in defined areas of medical device safety and performance.

Request clarity on the expected deliverables. A useful test report should identify the device and configuration tested, standards and methods used, test conditions, results, acceptance criteria where applicable, deviations, and any limitations affecting interpretation. These details support traceability long after the test date.

The strongest testing strategy is one that matches the evidence to the decision. Use internal capability to learn quickly, then use accredited testing where the result must carry formal technical and regulatory weight. Planning that boundary early gives engineering and regulatory teams a clearer path from prototype evidence to credible compliance documentation.